Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1950 2
1983 1
1984 1
1985 4
1986 4
1987 5
1988 4
1989 2
1990 4
1991 3
1992 1
1993 1
1994 1
1995 6
1996 6
1997 3
1998 6
1999 2
2000 2
2001 5
2002 8
2003 5
2004 3
2005 2
2006 2
2007 3
2008 7
2009 4
2010 3
2011 5
2012 5
2013 2
2015 5
2016 2
2017 3
2018 3
2020 4
2021 6
2022 5
2023 4
2024 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Khetan S, Segall N, Solis J, Brosz A, Fierro C, Schwartz H, Neuzil K, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Mascola J, Polakowski L, Ledgerwood J, Graham BS, Bennett H, Pajon R, Knightly C, Leav B, Deng W, Zhou H, Han S, Ivarsson M, Miller J, Zaks T; COVE Study Group. Baden LR, et al. N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30. N Engl J Med. 2021. PMID: 33378609 Free PMC article. Clinical Trial.
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
El Sahly HM, Baden LR, Essink B, Doblecki-Lewis S, Martin JM, Anderson EJ, Campbell TB, Clark J, Jackson LA, Fichtenbaum CJ, Zervos M, Rankin B, Eder F, Feldman G, Kennelly C, Han-Conrad L, Levin M, Neuzil KM, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Polakowski L, Mascola JR, Ledgerwood JE, Graham BS, August A, Clouting H, Deng W, Han S, Leav B, Manzo D, Pajon R, Schödel F, Tomassini JE, Zhou H, Miller J; COVE Study Group. El Sahly HM, et al. N Engl J Med. 2021 Nov 4;385(19):1774-1785. doi: 10.1056/NEJMoa2113017. Epub 2021 Sep 22. N Engl J Med. 2021. PMID: 34551225 Free PMC article. Clinical Trial.
Survivorship: Morbidity, Mortality, Malignancy.
Malloy KM, Pou AM. Malloy KM, et al. Among authors: pou am. Otolaryngol Clin North Am. 2017 Aug;50(4):853-866. doi: 10.1016/j.otc.2017.04.005. Otolaryngol Clin North Am. 2017. PMID: 28755707 Review.
Paraneoplastic syndromes.
Fueyo J, Gomez-Manzano C, Pascual J, Pou A. Fueyo J, et al. Among authors: pou a. Neurology. 1993 Jan;43(1):236. doi: 10.1212/wnl.43.1_part_1.236. Neurology. 1993. PMID: 8380908 No abstract available.
Dysferlin expression in monocytes: a source of mRNA for mutation analysis.
De Luna N, Freixas A, Gallano P, Caselles L, Rojas-García R, Paradas C, Nogales G, Dominguez-Perles R, Gonzalez-Quereda L, Vílchez JJ, Márquez C, Bautista J, Guerrero A, Salazar JA, Pou A, Illa I, Gallardo E. De Luna N, et al. Among authors: pou a. Neuromuscul Disord. 2007 Jan;17(1):69-76. doi: 10.1016/j.nmd.2006.09.006. Epub 2006 Oct 27. Neuromuscul Disord. 2007. PMID: 17070050
140 results